Precision BioSciences Inc (DTIL) — Financial Flexibility Index
Precision BioSciences Inc (DTIL) has a Financial Flexibility Index of -0.18x as of March 2026. Free cash flow of $-11.92 Million (operating CF $-11.94 Million minus capex $18.00K) represents 0% of total liabilities ($67.79 Million). Check DTIL PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Precision BioSciences Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Precision BioSciences Inc across 10 annual periods. See Precision BioSciences Inc (DTIL) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Precision BioSciences Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Precision BioSciences Inc. For the full company profile including market capitalisation, see Precision BioSciences Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.06x | $-65.76 Million | $-65.84 Million | $62.17 Million | ▼ -45.4% |
| 2024 | -0.73x | $-58.20 Million | $-58.45 Million | $80.00 Million | ▼ -25.3% |
| 2023 | -0.58x | $-81.84 Million | $-84.11 Million | $140.92 Million | ▼ -143.2% |
| 2022 | -0.24x | $-42.43 Million | $-45.75 Million | $177.74 Million | ▼ -468.9% |
| 2021 | -0.04x | $-5.05 Million | $-10.85 Million | $120.33 Million | ▲ +94.6% |
| 2020 | -0.78x | $-82.36 Million | $-87.39 Million | $105.73 Million | ▼ -54.2% |
| 2019 | -0.51x | $-48.97 Million | $-73.64 Million | $96.92 Million | ▼ -38.3% |
| 2018 | -0.37x | $-36.05 Million | $-51.72 Million | $98.64 Million | ▼ -94.6% |
| 2017 | -0.19x | $-18.60 Million | $-24.17 Million | $99.05 Million | ▼ -120.5% |
| 2016 | 0.91x | $94.35 Million | $92.27 Million | $103.16 Million | — |